Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia

Shock

Volumn 8, Issue 5, 1997, Pages 341-348

  Meistrell III, Malcolm E ^a   Botchkina, Galina I ^a   Wang, Haichao ^a   Di Santo, Elena ^b   Cockroft, Kevin M ^a   Bloom, Ona ^a   Vishnubhakat, Jaideep M ^a   Ghezzi, Pietro ^b   Tracey, Kevin J ^a,c  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c Picower Institute Press 350   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HYDRAZONE DERIVATIVE; NEUROPROTECTIVE AGENT; SEMAPIMOD; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; DRUG ANTAGONISM; HUMAN; IMMUNOHISTOCHEMISTRY; LEWIS RAT; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT;

ANIMALS; ANTIBODIES; BRAIN ISCHEMIA; CEREBRAL CORTEX; CEREBROVASCULAR DISORDERS; HUMANS; HYDRAZONES; IMMUNOHISTOCHEMISTRY; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, INBRED LEW; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031262936     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199711000-00005     Document Type: Article

References (55)

1. Anonymous: Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333:1581-1587, 1995.
2. Liu T, Clark RK, McDonnell PC, et al: Tumor necrosis factor-α expression in ischemic neurons. Stroke 25:1481-1488, 1994.
3. Dawson DA, Martin D, Hallenbeck JM: Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neurosci Lett 218:41-44, 1996.
4. Nawashiro H, Martin D, Hallenbeck JM: Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J Cereb Blood Flow Metab 17:229-232, 1997.
5. Shohami E, Bass R, Wallach D, Yamin A, Gallily R: Inhibition of tumor necrosis factor alpha activity in rat brain is associated with cerebroprotection after closed head injury. J Cereb Blood Flow Metab 16:378-384, 1996.
6. Bruce AJ, Boling W, Kindy M, et al: Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 2:788-789, 1996.
7. Sherry BA, Gellin J, Fong Y, et al: Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. FASEB J 3:1956-1962, 1989.
8. Tracey KJ, Beutler B, Lowry SF, et al: Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474, 1986.
9. Aggarwal BB, Kohr WJ, Hass PE, et al: Human tumor necrosis factor. J Biol Chem 260:2345-2354, 1985.
10. Zimmerman GA, Meistrell M III, Bloom O, et al: Neurotoxicity of advanced glycation endproducts (AGEs) during focal stroke, and neuroprotective effects of aminoguanidine. Proc Natl Acad Sci USA 92:3744-3748, 1995.
11. Cockroft KM, Meistrell M III, et al: Cerebroprotective effects of aminoguanidine in a rodent model of stroke. Stroke 27:1393-1398, 1996.
12. Sharkey J, Butcher SP: Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature 371:336-339, 1994.
13. Brint S, Jacewicz M, Kiessling M, Tanabe J, Pulsinelli W: Focal brain ischemia in the rat: Methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J Cereb Blood Flow Metab 8:474-485, 1988.
14. Bianchi M, Ulrich P, Bloom O, et al: An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammatory and endotoxin lethality. Mol Med 1:254-266, 1995.
15. Bianchi M, Bloom O, Raabe T, et al: Suppression of Proinflammatory Cytokines in Monocytes by a Tetravalent Guanylhydrazone. J Exp Med 83:927-936, 1996.
16. Cohen, PS, Nakshaatri H, Dennis J, et al: CNI-1493 inhibits monocyte/ macrophage tumor necrosis factor by suppression of translation efficiency. Proc Natl Acad Sci USA 93:3967-3971, 1996.
17. Cohen PS, Schmidtmayerova H, Dennis J, et al: The critical role of p38 MAP kinase in T cell HIV-1 replication. Mol Med 3:339-346, 1997.
18. Cerami C, Xhang X, Ulrich P, Bianchi M, Tracey KJ, Berger BJ: High-performance liquid chromatographic method for guanylhydrazone compounds which prevent acute inflammation and toxic shock syndrome. J Chromatog 675:71-75, 1995.
19. Fink G, Yang J, Carter G, et al: A low molecular weight macrophage inhibitor decreases severity of pancreatitis through inhibition of IL-1 and TNF production. Surg Forum 47:137-139, 1997.
20. Martiney J, Rajan A, Cerami A, Tracey KJ, Brosnan CF: Suppression of acute experimental autoimmune encephalitis by CNI-1493, an inhibitor of TNF synthesis. J Invest Med 44:200, 1996 (abstract).
21. Denham W, Fink G, Yang J, Ulrich P, Tracey JJ, Norman J: Small molecule inhibition of TNF gene processing during acute pancreatitis prevents cytokine cascade progression and attenuates pancreatitis severity. Am Surgeon 1997. In press.
22. Villa P, Meazza C, Sironi M, et al: A low molecular weight TNF inhibitor (CNI-1493) protects mice from sepsis and sepsis-associated pulmonary infiltration. Eur Cytokine Network 7:506, 1997 (abstract).
23. Cockroft KM, Meistrell M III, Ulrich P, Cerami A, Tracey KJ: A novel inhibitor of inflammatory cytokine production (CNI-1493) is cerebroprotective in permanent focal cerebral ischemia. Surg Forum 47:568-570, 1999 (abstract).
24. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Stricter RM, Campbell DA Jr: Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 85:1936-1943, 1990.
25. Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P: Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237:1210-1212, 1987.
26. Hallenbeck JM, Dutka AJ, Vogel SN, Heldman E, Doron DA, Feuerstein G: Lipopolysaccharide-induced production of tumor necrosis factor activity in rats with and without risk factors for stroke. Brain Res 541:115-120, 1991.
27. Tracey KJ: Suppression of TNF and other proinflammatory cytokines by the tetravalent guanylhydrazone CNI-1493. J Endotoxin Res 3:12, 1997 (abstract).
28. Wong GHW, Goeddel DV: Induction of manganous superoxide dismutase by tumor necrosis factor: Possible protective mechanism. Science 242: 941-944, 1988.
29. Rothwell NJ, Luheshi GN: Brain TNF: Damage limitation or damaged reputation? Nat Med 2:746-747, 1996.
30. Tracey KJ, Vlassara H, Cerami A: Cachectin/TNF (tumour necrosis factor). Lancet 1:1122-1126, 1989.
31. Tracey KJ, Morgello S, Koplin B, et al: Metabolic effects of cachectin/ tumor necrosis factor are modified by site of production: Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominately acute anorexia. J Clin Invest 86:2014-2024, 1990.
32. Tureen J: Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood How in the rabbit: role of nitric oxide. J Clin Invest 95:1086-1091, 1995.
33. Tracey KJ, Lowry SF, Beutler B, Cerami A, Albert JD, Shires GT: Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential. J Exp Med 164:1368-1373, 1986.
34. Kagan BL, Baldwin RL, Munoz D, Wisnieski BJ: Formation of ionpermeable channels by tumor necrosis factor-alpha. Science 255:1427-1430, 1992.
35. Tracey KJ: Tumor necrosis factor. In Remick DG, Friedland JS (eds): Cytokines in Health and Disease. New York: Marcel Dekker, Inc., 1997, pp 223-240.
36. Pober JS: TNF as an activator of vascular endothelium. Ann Instit Pasteur 139:317-323, 1988.
37. Brett J, Gerlach H, Nawroth P, Steinberg S, Godman G, Stem D: Tumor necrosis factor/cachectin increases permeability of endothelial cell mono-layers by a mechanism involving regulatory G proteins. J Exp Med 169:1977-1991, 1989.
38. Decoster E, Vanhaesebroeck B, Vandenabeele P, Grooten J, Fiers W: Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor. J Biol Chem 270:18473-18478, 1995.
39. McLaurin J, D'Souza S, Stewart J, et al: Effect of tumor necrosis factor a and β on human oligodendrocytes and neurons in culture. Int J Dev Neurosci 13:369-381, 1995.
40. Wong G, Goeddel D: FAS antigen and p55 TNF receptor signal apoptosis through distinct pathways. J Immunol 152:1751-1755, 1994.
41. Rothwell NJ, Strijbos PJ: Cytokines in neurodegeneration and repair. Int J Dev Neurosci 13:179-185, 1995.
42. Fong Y, Tracey KJ, Moldawer LL, et al: Antibodies to cachectin/TNF reduce interleukin-1-beta and interleukin-6 appearance during lethal bacteremia. J Exp Med 170:1627-1633, 1989.
43. Tracey KJ: The acute and chronic pathophysiological effects of TNF: Mediation of septic shock and wasting (cachexia). In Beutler B (ed): Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. New York: Raven Press, 1992, pp 255-273.
44. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064, 1992.
45. Montague PR, Gancayco CD, Winn MJ, Marchase RB, Friedlander JJ: Role of NO production in NMDR receptor-mediated neurotransmitter release in cerebral cortex. Science 263:973-976, 1994.
46. Zhang J, Dawson V, Dawson T, Snyder S: Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263:687-690, 1994.
47. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA: Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265:1883-1885, 1994.
48. Relton JK, Rothwell NJ: Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 29:243-246, 1992.
49. Rothwell NJ, Relton JK: Involvement of interleukin-1 and lipocortin-1 in ischeamic brain damage. Cerebrovasc Brain Metab Rev 5:178-198, 1993.
50. Kaku DA, Giffard RG, Choi DW: Neuroprotective effects of glutamate antagonists and extracellular acidity. Science 260:1516-1518, 1993.
51. Choi DW: Excitotoxic cell death. J Neurobiol 23:1261-1276, 1992.
52. Minami M, Kuraishi Y, Satoh M: Effects of kainic acid on messenger RNA levels of IL-1β, IL-6, TNFα and life in the rat brain. Biochem Biophys Res Commun 176:593-598, 1991.
53. Chao CC, Hu S: Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev Neurosci 16:172-179, 1994.
54. Lee JC, Laydon JT, McDonnell PC, et al: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746, 1995.
55. Gass P, Kiessling M, Bading H: Regionally selective stimulation of mitogen activated protein (MAP) kinase tyrosine phosphorylation after generalized seizures in the rat brain. Neurosci Lett 162:39-42, 1993.